Invictus RG’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,527
Closed -$250K 397
2017
Q4
$250K Buy
1,527
+1,347
+748% +$242K 0.26% 217
2017
Q3
$37K Sell
180
-242
-57% -$56.3K 0.03% 390
2017
Q2
$103K Buy
+422
New +$99.2K 0.08% 399
2017
Q1
Sell
-1,457
Closed -$306K 894
2016
Q4
$306K Buy
+1,457
New +$302K 0.21% 195

Other funds holding AGN

Invictus RG's AGN Position: Q1 2018 in Review

Invictus RG sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,527 shares — an estimated $250K sold.

Invictus RG first reported a position in AGN in Q4 2016 and held it in 4 quarters. The position peaked at $306K in Q4 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Invictus RG reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Invictus RG sold 1,527 Allergan plc shares in Q1 2018, an estimated $250K.
  • Invictus RG first reported a position in Allergan plc in Q4 2016 and held it in 4 quarters.
  • Invictus RG's Allergan plc position peaked at $306K in Q4 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Invictus RG's 13F filing for Q1 2018, filed 14 May 2018.